SPRAVATO Prior Authorization Checklist for Clinics
Use a SPRAVATO prior authorization checklist for current FDA labeling and REMS context, payer and benefit pathway, site and provider requirements, qualified clinical evidence, acquisition, scheduling, submission, approval scope, monitoring workflow, and reauthorization.
On this page: Direct answer
Direct answer
SPRAVATO prior authorization checklist: what operators need to know
Use a SPRAVATO prior authorization checklist for current FDA labeling and REMS context, payer and benefit pathway, site and provider requirements, qualified clinical evidence, acquisition, scheduling, submission, approval scope, monitoring workflow, and reauthorization. Verify the latest FDA labeling and product-specific REMS separately from the current payer policy.
A SPRAVATO prior authorization checklist should coordinate the exact payer, plan, benefit and acquisition pathway, network, prescriber, certified healthcare setting, location, indication context, requested course, current policy, qualified clinical evidence, submission, written decision, scheduling, and reauthorization. FDA-approved labeling and the product-specific REMS are separate from payer coverage criteria and both need current verification.
SPRAVATO is a prescription treatment with boxed warnings and a restricted REMS; outpatient administration and monitoring requirements are described in current FDA materials. This guide is an administrative workflow, not prescribing, diagnosis, safety, dosing, or treatment advice. Qualified clinicians and certified settings must follow current labeling, REMS, professional judgment, and applicable requirements.
Key takeaways
The short version
- Verify the latest FDA labeling and product-specific REMS separately from the current payer policy.
- Confirm medical-versus-pharmacy benefit, acquisition, dispensing, certified-site, provider, and network pathways.
- Map payer criteria only to current evidence authored or approved by qualified clinicians.
- Reconcile course, dates, units, site, provider, conditions, expiration, and reauthorization from the written decision.
- Coordinate authorization, medication logistics, scheduling, REMS operations, monitoring, and fallback without implying payment.
Take the template with you
Free to copy · no email required
Coordinate current product, payer, clinical, site, acquisition, scheduling, and decision evidence without collapsing their requirements.
# SPRAVATO prior authorization checklist ## Current sources - FDA label version / owner / date: - Product REMS version / site status / date: - Payer policy / version / effective date: ## Coverage and request - Member / plan / benefit / authorization entity: - Acquisition / dispensing / provider / certified setting / network: - Drug and administration request / dates / visits / units / codes: ## Evidence and decision - Criterion / source / qualified author / date: - Missing / conflicting / stale / N-A / clarification: - Submission / receipt / reference / clock: - Approved drug / administration / site / dates / units / conditions: - Reauthorization / denial / rights / deadline / next owner:
1. SPRAVATO prior authorization checklist
| Domain | Verify | Authoritative evidence |
|---|---|---|
| Product requirements | Current FDA label, indication and limitations context, warnings, administration, monitoring, and REMS | Current FDA labeling and REMS reviewed by qualified owners |
| Coverage pathway | Payer, product, medical or pharmacy benefit, acquisition route, network, entity, and coordination | Plan, payer, contract, portal, transaction, call reference, and response |
| Setting and provider | Certified setting, prescriber, administering roles, facility, site, enrollment, and payer participation | REMS status plus credentialing, network, and organizational records |
| Clinical criteria | Indication context, history, current treatment, assessments, safety or other fields required | Qualified clinical source, author, date, version, and reviewer |
| Request | Initial or continuation, ordered course, dates, visits, units, codes, drug and administration components | Order and payer request reviewed for consistency |
| Decision | Approved product and administration scope, provider, site, dates, units, conditions, expiration, and adverse details | Written decision reconciled before reliance |
2. Keep FDA, REMS, payer, and clinical sources separate
- Use the current FDA label for approved prescribing information and safety requirements—not a payer policy or old summary
- Use current product-specific REMS materials for certification, enrollment, administration, monitoring, dispensing, and documentation duties
- Use current plan policy, formulary or medical policy, portal, forms, benefit response, and payer confirmation for coverage
- Use qualified clinical records for diagnosis context, history, current treatment, assessments, ordering, safety review, and decisions
- Use organizational records for site readiness, trained roles, credentialing, network, scheduling, capacity, emergency process, and logistics
- Version each source, assign an owner, and recheck when labeling, REMS, policy, benefit, provider, site, order, or course changes
3. Build and review the payer packet
- 01
Resolve the pathway
Confirm member, product, medical or pharmacy benefit, entity, acquisition and dispensing route, billing, network, certified site, provider, and contact.
- 02
Retrieve current criteria
Record policy, version, indication-specific requirements, request fields, channel, deadline, correction route, and appeal instructions.
- 03
Map evidence
Connect each criterion to the authoritative record, qualified author, observation date, value or narrative, reviewer, status, and packet location.
- 04
Resolve gaps
Mark missing, conflicting, stale, not applicable, payer clarification, or pending clinical review. Do not infer history, response, diagnosis, assessment, safety, or treatment decisions.
- 05
Submit and prove
Review member, benefit, drug, service, provider, site, dates, units, codes, sources, recipient, final version, and authority; preserve receipt and reference.
4. Reconcile authorization with clinic operations
| Workstream | Reconcile from current sources | Do not assume |
|---|---|---|
| Authorization | Product, administration, provider, certified site, dates, visits or units, conditions, expiration, and reauthorization | Drug approval covers administration or every site |
| Acquisition | Ordering, dispensing, delivery, inventory, patient-specific product, storage, rejected claim, and return process | Authorization equals successful acquisition or payment |
| Scheduling | Clinical order, medication availability, capacity, monitoring block, transportation and discharge policy, and contingency | A normal office appointment is sufficient |
| Visit | Current label, REMS, qualified decisions, administration, monitoring, documentation, and emergency readiness | Authorization software directs clinical care |
| Billing | Benefit route, product and administration codes, units, documentation, claim route, response, and correction | Authorization guarantees payment |
| Continuation | Clinical decision, payer requirements, completed course, current evidence, next request, and expiration | Initial approval automatically renews |
5. Prepare continuation, reauthorization, and appeal
- Work backward from expiration and payer due dates for qualified assessment, documentation, review, submission, questions, and fallback
- Track requested, authorized, scheduled, completed, canceled, rescheduled, unavailable, billed, and remaining visits separately
- Use only clinician-authored or approved evidence for response, treatment, assessments, safety, continuation, frequency, or clinical criteria
- For adverse decisions, preserve reason, policy, evidence, notice, rights, deadline, review route, appeal route, and requested action
- Separate benefit, network, acquisition, site, provider, administrative, missing-information, medical-necessity, coding, and claim issues
- Confirm outcome, corrected scope, medication logistics, appointment impact, patient communication, next review, and root cause
Common questions
Answers before you build.
Does SPRAVATO require prior authorization?+
Many plans may require prior authorization, but requirements vary by payer, product, benefit pathway, indication context, prescriber, certified setting, network, acquisition route, requested service, and date. Verify the current plan source.
What documentation is needed for SPRAVATO authorization?+
Use current payer criteria. Requirements may address member and benefit data, indication context, treatment history and response, current treatment, assessments, prescriber and site, requested course, product and administration details, and qualified signatures or records.
Is REMS certification the same as insurance authorization?+
No. The product-specific REMS establishes FDA-required safety-program conditions, while payer authorization addresses coverage under a plan. Credentialing, network, acquisition, clinical ordering, scheduling, and billing are also distinct.
Does authorization guarantee payment?+
No. Payment can still depend on eligibility, benefit, network, coding, units, provider and site, acquisition, documentation, claim submission, coordination of benefits, contract terms, and payer adjudication.
Practical closeout
Use this operator checklist.
- Verify the latest FDA labeling and product-specific REMS separately from the current payer policy.
- Confirm medical-versus-pharmacy benefit, acquisition, dispensing, certified-site, provider, and network pathways.
- Map payer criteria only to current evidence authored or approved by qualified clinicians.
- Reconcile course, dates, units, site, provider, conditions, expiration, and reauthorization from the written decision.
- Coordinate authorization, medication logistics, scheduling, REMS operations, monitoring, and fallback without implying payment.
Continue through the cluster
Verified customer case studies are added only with customer permission and supporting evidence; none is implied by these operational examples.
Sources & methodology
Trace the operational claims.
Marsa Health Editorial reviewed the primary and research sources below on July 22, 2026. We translate them into workflow controls, distinguish proposals from final rules, and flag where plan, program, state, contract, or clinical requirements vary.
- 01SPRAVATO (esketamine) Prescribing Information U.S. Food and Drug AdministrationFDA-approved prescribing information describing indications, limitations, boxed warnings, administration, monitoring, and the restricted SPRAVATO REMS. Clinicians must use current labeling and clinical judgment.Accessed or rechecked July 22, 2026
- 02Risk Evaluation and Mitigation Strategies U.S. Food and Drug AdministrationFDA overview of REMS as required drug-safety programs for certain medications; current product-specific REMS materials control over summaries.Accessed or rechecked July 22, 2026
- 03Medicare Coverage Database Centers for Medicare & Medicaid ServicesOfficial search for current national and local Medicare coverage documents. Users must select the relevant jurisdiction, effective version, service, and linked billing article.Accessed or rechecked July 22, 2026
- 04Medicare Part D coverage determinations Centers for Medicare & Medicaid ServicesOfficial overview of Part D coverage determinations, including prior authorization and other utilization-management requirements.Accessed or rechecked July 22, 2026
- 05CMS Interoperability and Prior Authorization Final Rule CMS-0057-F Centers for Medicare & Medicaid ServicesCurrent implementation dates, decision timeframes, denial-reason requirements, metrics, and API provisions for impacted payers.Accessed or rechecked July 22, 2026
- 06How to appeal an insurance company decision Centers for Medicare & Medicaid ServicesFederal overview of internal appeals, external review, notices, and general appeal timing. Plan and state rules can differ.Accessed or rechecked July 22, 2026
- 07Minimum Necessary Requirement U.S. Department of Health and Human ServicesHIPAA guidance on limiting uses, disclosures, and requests for protected health information when the standard applies.Accessed or rechecked July 22, 2026
- 08Autism services Medicaid.govFederal Medicaid overview and guidance collection on autism services; state coverage and operational requirements vary.Accessed or rechecked July 22, 2026
Organizational author. Editorial review covers source accuracy, search intent, workflow boundaries, and human-oversight requirements. This material is educational and does not provide clinical, legal, coding, or coverage advice.
No named clinical or legal expert reviewer is attributed to this version. Marsa Health does not invent reviewer credentials.
Read our editorial methodRevision history
What changed and when
July 22, 2026
Initial publication, source review, and operational editing.